Therapeutic effects of subthalamic nucleus deep brain stimulation on anxiety and depression in Parkinson's disease patients

Lu, 2020, Correlation between programmed stimulation parameters and their efficacy after deep brain electrode implantation for Parkinson’s disease, J Neurorestoratol, 8, 53, 10.26599/JNR.2019.9040018 Wichmann, 2016, Deep brain stimulation for movement disorders of basal Ganglia origin: restoring function or functionality?, Neurotherapeutics, 13, 264, 10.1007/s13311-016-0426-6 Birchall, 2017, The effect of unilateral subthalamic nucleus deep brain stimulation on depression in Parkinson’s disease, Brain Stimul, 10, 651, 10.1016/j.brs.2016.12.014 Berg, 2013, Changing the research criteria for the diagnosis of Parkinson’s disease: obstacles and opportunities, Lancet Neurol, 12, 514, 10.1016/S1474-4422(13)70047-4 Zach, 2017, Diagnostics of clinical and prodromal idiopathic Parkinson’s disease: new criteria, Nervenarzt, 88, 356, 10.1007/s00115-017-0290-6 Goetz, 2008, Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results, Mov Disord, 23, 2129, 10.1002/mds.22340 Hoehn, 1967, Parkinsonism: onset, progression and mortality, Neurology, 17, 427, 10.1212/WNL.17.5.427 Tomlinson, 2010, Systematic review of levodopa dose equivalency reporting in Parkinson’s disease, Mov Disord, 25, 2649, 10.1002/mds.23429 Zhang, 2021, Relationship between electrode position of deep brain stimulation and motor symptoms of Parkinson’s disease, BMC Neurol, 21, 122, 10.1186/s12883-021-02148-1 Horn, 2017, Connectivity Predicts deep brain stimulation outcome in Parkinson disease, Ann Neurol, 82, 67, 10.1002/ana.24974 Chen, 2015, The study on a telemedicine interaction mode for Deep Brain Stimulation postoperative follow-up, Annu Int Conf IEEE Eng Med Biol Soc, 2015, 186 Wakabayashi, 2007, Lewy body in Parkinson’s disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates, Neuropathology, 27, 494, 10.1111/j.1440-1789.2007.00803.x Dickson, 2009, Neuropathology of non-motor features of Parkinson disease, Parkinsonism Relat Disord, 15, S1, 10.1016/S1353-8020(09)70769-2 Sjödahl Hammarlund, 2012, Motor and non-motor predictors of illness-related distress in Parkinson’s disease, Parkinsonism Relat Disord, 18, 299, 10.1016/j.parkreldis.2011.10.015 Yin, 2018, Effect of general anesthesia on electrophysiology and postoperative effect of deep brain stimulation for subthalamic nucleus in Parkinson’s disease (in Chinese), Chin J Neuromed, 17, 685 Wang, 2009, Long-term effects of bilateral deep brain stimulation of the subthalamic nucleus on depression in patients with Parkinson’s disease, Parkinsonism Relat Disord, 15, 587, 10.1016/j.parkreldis.2009.02.006 Dulski, 2019, The impact of subthalamic deep brain stimulation on sleep and other non-motor symptoms in Parkinson’s disease, Parkinsonism Relat Disord, 64, 138, 10.1016/j.parkreldis.2019.04.001 Birchall, 2017, The effect of unilateral subthalamic nucleus deep brain stimulation on depression in Parkinson’s disease, Brain Stimul, 10, 651, 10.1016/j.brs.2016.12.014 Jaafari, 2009, Deep brain stimulation, Parkinson’s disease and neuropsychiatric complications, Presse Med, 38, 1335, 10.1016/j.lpm.2008.11.019 Castelli, 2006, Chronic deep brain stimulation of the subthalamic nucleus for Parkinson’s disease: effects on cognition, mood, anxiety and personality traits, Eur Neurol, 55, 136, 10.1159/000093213 Kurcova, 2018, Bilateral subthalamic deep brain stimulation initial impact on nonmotor and motor symptoms in Parkinson’s disease: an open prospective single institution study, Medicine (Baltimore), 97, 10.1097/MD.0000000000009750 Deuschl, 2006, A randomized trial of deep-brain stimulation for Parkinson’s disease, N Engl J Med, 355, 896, 10.1056/NEJMoa060281 Blomstedt, 2008, Acute severe depression induced by intraoperative stimulation of the substantia nigra: a case report, Parkinsonism Relat Disord, 14, 253, 10.1016/j.parkreldis.2007.04.005 Soulas, 2008, Attempted and completed suicides after subthalamic nucleus stimulation for Parkinson’s disease, J Neurol Neurosurg Psychiatry, 79, 952, 10.1136/jnnp.2007.130583 Gallagher, 2012, Psychosis, apathy, depression and anxiety in Parkinson’s disease, Neurobiol Dis, 46, 581, 10.1016/j.nbd.2011.12.041 Schrag, 2001, What contributes to depression in Parkinson’s disease?, Psychol Med, 31, 65, 10.1017/S0033291799003141 Bronstein, 2011, Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues, Arch Neurol, 68, 165, 10.1001/archneurol.2010.260 Follett, 2010, Pallidal versus subthalamic deep-brain stimulation for Parkinson’s disease, N Engl J Med, 362, 2077, 10.1056/NEJMoa0907083 McDonald, 2012, Deep brain stimulation of the subthalamic nucleus improves sense of well-being in Parkinson’s disease, Mov Disord, 27, 372, 10.1002/mds.24035 Lyons, 2005, Long-term benefits in quality of life provided by bilateral subthalamic stimulation in patients with Parkinson disease, J Neurosurg, 103, 252, 10.3171/jns.2005.103.2.0252 Daniels, 2011, Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson’s disease predictable?, Mov Disord, 26, 2516, 10.1002/mds.23907 Bronstein, 2011, Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues, Arch Neurol, 68, 165, 10.1001/archneurol.2010.260